HAART accounts for large increase in HIV/AIDS costs in Canada

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.429, 2003-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HAART accounts for large increase in HIV/AIDS costs in Canada

Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

HAART in HIV/AIDS Treatments: Future Trends

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 18, Iss. 1, 2018-03 ,pp. : 15-22

Bentham Science Publishers

Access to resources Recommend Favorite

Economic Costs to Business of the HIV/AIDS Epidemic

By Gordon G. Liu Jeff J. Guo Scott R. Smith

PharmacoEconomics, Vol. 22, Iss. 18, 2004-01 ,pp. : 1181-1194

Adis International

Access to resources Recommend Favorite

Modelling outcomes and costs of HIV/AIDS therapy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 360, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Indirect costs of HIV/AIDS substantial in Spain

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 433, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite